Can Flow Cytometry Detect Successful Ticlopidine Treatment in Patients with VVI Pacemakers?

Journal of Invasive Cardiology

Volumn 11, Issue 8, 1999, Pages 471-474

  Koşar, Feridun ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

Platelet activation status; Platelet surface markers

Indexed keywords

ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; TICLOPIDINE;

ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD; CELL MEMBRANE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HEART BLOCK; HUMAN; MALE; METABOLISM; MIDDLE AGED; STANDARD; THROMBOCYTE; THROMBOCYTE ACTIVATION; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; BLOOD PLATELETS; CELL MEMBRANE; FEMALE; FLOW CYTOMETRY; HEART BLOCK; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 0005992333     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Curzi GF, Moccheggranni R, Ciampani N, et al. Thromboembolism during VVI permanent pacing cardiac pacing: Electro-physiology and tachyarrhythmias. In: Gomez P (ed). Cardiac Pacing. Madrid, Spain: Editorial Grouz, 1985: pp. 1203-1206.
2. Sasaki S, Takeuchi A, Ahzeki M, et al. Long-term follow-up of paced patients with sick sinus syndrome. Cardiac pacing. In: Steinbach K (ed.). Proceedings of the 7th World Symposium on Cardiac Pacing. Darmstadt, The Netherlands: Steinkopff Verlag, 1983: pp. 85-89.